Strut Health Review: One Charge, Four GLP-1s, and a Page That Argues With Itself

One charge a month, and the number on the page is all of it. Compounded oral semaglutide is $99 for a 30-day supply; injectable semaglutide with B6 is $149; oral tirzepatide is $239 one-time or $199 on auto-refill; injectable tirzepatide is $325 one-time with a $199 auto-refill rate that its own page can’t reconcile. There’s no membership, no consultation charge and no shipping fee — Strut's pages say "Includes Provider & Medication" and "No Hidden Fees." That’s unusual: Ro, Hers and Mochi all bill a membership separately from the drug.

It’s the only price Strut states, and it’s all-in — but treat it carefully. This is a compounded sublingual lozenge, not FDA-approved Wegovy, and Strut says so on the page. The figure appears twice on that page: once as "As low as $99/mo" beneath a "Save 21% with auto-refill" badge, and once as a flat "30-DAY SUPPLY · $99" under the heading "Simple, Transparent Pricing." If the 21% is real, the price without a standing order is higher — and Strut never prints it. This review publishes the $99 because it’s what Strut publishes, and flags that the without-auto-refill figure is missing.

At the published monthly figures, twelve months of the oral semaglutide lozenge is $1,188 and the injectable is $1,788. Oral tirzepatide is $2,868 at the one-time price or $2,388 on auto-refill. Injectable tirzepatide is $3,900 at $325 a month, or $2,388 if the $199 auto-refill rate is honored — a $1,512 gap on the same drug, created entirely by a discount badge the page's own arithmetic doesn’t support.

Because two pricing modules from different eras of the site sit on the same page. The oral tirzepatide page is internally consistent: $239 for 30 days, less 17%, is $198, and Strut advertises $199. The injectable page uses the same $199 auto-refill figure against a $325 30-day price, which is a 39% discount, and badges it "Save 14%." Both pages also print "Just $6.63" a day, which is $199 ÷ 30 — correct for the auto-refill rate and wrong for the price it’s printed under. All four figures were read on August 7, 2026. If you’re quoted something else at checkout, this is why.

Almost certainly, and possibly further than you expect. Strut's own checkout returns a list of 51 places it will ship to: 49 states plus Washington, D.C. and Puerto Rico. Arkansas is the one US state missing from that list. Puerto Rico is worth noting on its own — Ro, for example, excludes US territories outright, so for a Puerto Rico address Strut is one of very few options in this category.

It concerned labels and marketing copy, not the drug. On February 20, 2026 the FDA wrote to Strut Health, LLC about struthealth.com, saying the pictured compounded semaglutide and tirzepatide labels carried the Strut name and so suggested "Strut is the compounder of those drugs when in fact it is not," and objecting to claims including "Generic Zepbound, Mounjaro." Those are misbranding findings under FDCA 502(a) and 502(bb) — the same class of letter established manufacturers receive — and the letter alleges nothing about sterility, potency or contamination. A warning letter is a public regulatory communication, not a finding of illegal activity. Strut's pages today carry the compounding disclaimer up front and no longer use the word "generic."

You can cancel; you won’t get money back. Every product page says "Cancel anytime," and auto-refill is a plan you opt into rather than the only way to buy. But Strut's return and refund policy states that for "all medications that leave the pharmacy, we are unable to accept returns or offer refunds due to government regulations," and that it can’t refund cancellations received after the pharmacy has processed the order. Replacements are limited to defective or damaged items reported within two weeks. That policy was last modified in September 2021, which is a long time in this category.